I-FLICE, a novel inhibitor of tumor necrosis factor receptor-1 and CD-95 induced apoptosis
    1.
    发明授权
    I-FLICE, a novel inhibitor of tumor necrosis factor receptor-1 and CD-95 induced apoptosis 失效
    I-FLICE,一种新型的肿瘤坏死因子受体-1抑制剂和CD-95诱导的细胞凋亡

    公开(公告)号:US06680171B1

    公开(公告)日:2004-01-20

    申请号:US09489155

    申请日:2000-01-21

    IPC分类号: C07H2104

    CPC分类号: C12N9/6475 A61K38/00

    摘要: The present invention relates to a novel I-FLICE-1 or I-FLICE-2 protein which is a novel inhibitor of INFR-1 and CD-95 induced apoptosis. In particular, isolated nucleic acid molecules are provided encoding the human I-FLICE-1 or I-FLICE-2 protein. I-FLICE-1 or I-FLICE-2 polypeptides are also provided as are vectors, host cells and recombinant methods for producing the same. The invention further relates to screening methods for identifying agonists and antagonists of I-FLICE-1 or I-FLICE-2 activity. Also provided are therapeutic methods for treating diseases and disorders associated with apoptosis.

    摘要翻译: 本发明涉及一种新型的I-FLICE-1或I-FLICE-2蛋白,其是INFR-1和CD-95诱导的凋亡的新型抑制剂。 特别地,提供编码人I-FLICE-1或I-FLICE-2蛋白的分离的核酸分子。 还提供I-FLICE-1或I-FLICE-2多肽,载体,宿主细胞和用于制备它的重组方法。 本发明还涉及用于鉴定I-FLICE-1或I-FLICE-2活性的激动剂和拮抗剂的筛选方法。 还提供了用于治疗与凋亡相关的疾病和病症的治疗方法。

    I-flice, a novel inhibitor of tumor necrosis factor receptor-1 and CD-95 induced apoptosis
    2.
    发明授权
    I-flice, a novel inhibitor of tumor necrosis factor receptor-1 and CD-95 induced apoptosis 失效
    I-flice,一种新型的肿瘤坏死因子受体-1抑制剂和CD-95诱导的细胞凋亡

    公开(公告)号:US06623938B2

    公开(公告)日:2003-09-23

    申请号:US09009893

    申请日:1998-01-21

    IPC分类号: C12P2106

    CPC分类号: C12N9/6475 A61K38/00

    摘要: The present invention relates to a novel I-FLICE-1 or I-FLICE-2 protein which is a novel inhibitor of TNFR-1 and CD-95 induced apoptosis. In particular, isolated nucleic acid molecules are provided encoding the human I-FLICE-1 or I-FLICE-2 protein. I-FLICE-1 or I-FLICE-2 polypeptides are also provided as are vectors, host cells and recombinant methods for producing the same. The invention further relates to screening methods for identifying agonists and antagonists of I-FLICE-1 or I-FLICE-2 activity. Also provided are therapeutic methods for treating diseases and disorders associated with apoptosis.

    摘要翻译: 本发明涉及一种新型的I-FLICE-1或I-FLICE-2蛋白,其是TNFR-1和CD-95诱导的细胞凋亡的新型抑制剂。 特别地,提供编码人I-FLICE-1或I-FLICE-2蛋白的分离的核酸分子。 还提供I-FLICE-1或I-FLICE-2多肽,载体,宿主细胞和用于制备它的重组方法。 本发明还涉及用于鉴定I-FLICE-1或I-FLICE-2活性的激动剂和拮抗剂的筛选方法。 还提供了用于治疗与凋亡相关的疾病和病症的治疗方法。

    Death domain containing receptor-4 antibodies
    4.
    发明授权
    Death domain containing receptor-4 antibodies 有权
    含有受体-4抗体的死亡域

    公开(公告)号:US06461823B1

    公开(公告)日:2002-10-08

    申请号:US09448868

    申请日:1999-11-24

    IPC分类号: G01N33567

    CPC分类号: C07K14/70578

    摘要: The present invention relates to novel Death Domain Containing Receptor-4 (DR4) proteins which are members of the tumor necrosis factor (TNF) receptor family. In particular, isolated nucleic acid molecules are provided encoding the human DR4 proteins. DR4 polypeptides are also provided as are vectors, host cells and recombinant methods for producing the same. The invention further relates to screening methods for identifying agonists and antagonists of DR4 activity.

    摘要翻译: 本发明涉及作为肿瘤坏死因子(TNF)受体家族成员的新的含有死亡域的受体-4(DR4)蛋白。 特别地,提供编码人DR4蛋白的分离的核酸分子。 还提供了DR4多肽,载体,宿主细胞和用于制备它们的重组方法。 本发明还涉及用于鉴定DR4活性的激动剂和拮抗剂的筛选方法。

    Death domain containing receptor-4
    5.
    发明授权
    Death domain containing receptor-4 有权
    死亡域含受体4

    公开(公告)号:US06433147B1

    公开(公告)日:2002-08-13

    申请号:US09565918

    申请日:2000-05-05

    IPC分类号: C07K14705

    摘要: The present invention relates to novel Death Domain Containing Receptor-4 (DR4) proteins which are members of the tumor necrosis factor (TNF) receptor family. In particular, isolated nucleic acid molecules are provided encoding the human DR4 proteins. DR4 polypeptides are also provided as are vectors, host cells and recombinant methods for producing the same. The invention further relates to screening methods for identifying agonists and antagonists of DR4 activity and methods for using DR4 polynucleotides and polypeptides.

    摘要翻译: 本发明涉及作为肿瘤坏死因子(TNF)受体家族成员的新的含有死亡域的受体-4(DR4)蛋白。 特别地,提供编码人DR4蛋白的分离的核酸分子。 还提供了DR4多肽,载体,宿主细胞和用于制备它们的重组方法。 本发明还涉及用于鉴定DR4活性的激动剂和拮抗剂的筛选方法以及使用DR4多核苷酸和多肽的方法。

    Death domain containing receptor 4 antibodies and methods
    6.
    发明授权
    Death domain containing receptor 4 antibodies and methods 有权
    含有受体4抗体的死亡域和方法

    公开(公告)号:US07452538B2

    公开(公告)日:2008-11-18

    申请号:US10648786

    申请日:2003-08-27

    摘要: The present invention relates to novel Death Domain Containing Receptor-4 (DR4) proteins which are members of the tumor necrosis factor (TNF) receptor family. In particular, isolated nucleic acid molecules are provided encoding the human DR4 proteins. DR4 polypeptides are also provided as are vectors, host cells and recombinant methods for producing the same. The invention further relates to screening methods for identifying agonists and antagonists of DR4 activity and methods for using DR4 polynucleotides and polypeptides. The invention also relates to the treatment of diseases associated with reduced or increased levels of apoptosis using antibodies specific for DR4, which may be agonists and/or antagonists of DR4 activity.

    摘要翻译: 本发明涉及作为肿瘤坏死因子(TNF)受体家族成员的新的含有死亡域的受体-4(DR4)蛋白。 特别地,提供编码人DR4蛋白的分离的核酸分子。 还提供了DR4多肽,载体,宿主细胞和用于制备它们的重组方法。 本发明还涉及用于鉴定DR4活性的激动剂和拮抗剂的筛选方法以及使用DR4多核苷酸和多肽的方法。 本发明还涉及使用DR4特异性抗体(其可以是DR4活性的激动剂和/或拮抗剂)的减少或增加的细胞凋亡相关疾病的治疗。

    Death domain containing receptor 4 nucleic acids and methods
    7.
    发明授权
    Death domain containing receptor 4 nucleic acids and methods 失效
    含有受体4核酸的死亡域和方法

    公开(公告)号:US06342363B1

    公开(公告)日:2002-01-29

    申请号:US09013895

    申请日:1998-01-27

    IPC分类号: G01N3353

    CPC分类号: C07K14/70578

    摘要: The present invention relates to novel Death Domain Containing Receptor-4 (DR4) proteins which are members of the tumor necrosis factor (TNF) receptor family. In particular, isolated nucleic acid molecules are provided encoding the human DR4 proteins. DR4 polypeptides are also provided as are vectors, host cells and recombinant methods for producing the same. The invention further relates to screening methods for identifying agonists and antagonists of DR4 activity.

    摘要翻译: 本发明涉及作为肿瘤坏死因子(TNF)受体家族成员的新的含有死亡域的受体-4(DR4)蛋白。 特别地,提供编码人DR4蛋白的分离的核酸分子。 还提供了DR4多肽,载体,宿主细胞和用于制备它们的重组方法。 本发明还涉及用于鉴定DR4活性的激动剂和拮抗剂的筛选方法。

    Death domain containing receptor 4 antibodies and methods
    10.
    发明授权
    Death domain containing receptor 4 antibodies and methods 有权
    含有受体4抗体的死亡域和方法

    公开(公告)号:US08329179B2

    公开(公告)日:2012-12-11

    申请号:US12010108

    申请日:2008-01-18

    摘要: The present invention relates to novel Death Domain Containing Receptor-4 (DR4) proteins which are members of the tumor necrosis factor (TNF) receptor family. In particular, isolated nucleic acid molecules are provided encoding the human DR4 proteins. DR4 polypeptides are also provided as are vectors, host cells and recombinant methods for producing the same. The invention further relates to screening methods for identifying agonists and antagonists of DR4 activity and methods for using DR4 polynucleotides and polypeptides. The invention also relates to the treatment of diseases associated with reduced or increased levels of apoptosis using antibodies specific for DR4, which may be agonists and/or antagonists of DR4 activity.

    摘要翻译: 本发明涉及作为肿瘤坏死因子(TNF)受体家族成员的新的含有死亡域的受体-4(DR4)蛋白。 特别地,提供编码人DR4蛋白的分离的核酸分子。 还提供了DR4多肽,载体,宿主细胞和用于制备它们的重组方法。 本发明还涉及用于鉴定DR4活性的激动剂和拮抗剂的筛选方法以及使用DR4多核苷酸和多肽的方法。 本发明还涉及使用DR4特异性抗体(其可以是DR4活性的激动剂和/或拮抗剂)的减少或增加的细胞凋亡相关疾病的治疗。